細胞溶解市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、細胞タイプ別、エンドユーザー別、地域別、競合市場別、2020-2030年

細胞溶解の世界市場は、2024年に31億6,000万米ドルと評価され、2030年には48億7,000万米ドルに達すると予測され、予測期間中のCAGRは7.47%で成長します。

同市場は、製薬、バイオテクノロジー、ヘルスケア分野における細胞ベースの研究・診断アプリケーションの需要増加により、大きな成長を遂げています。細胞溶解-細胞を破壊してその内部成分にアクセスする-は、分子生物学、バイオプロセス、臨床診断における基礎的なステップです。

バイオ医薬品業界の拡大、標的治療と個別化医療へのシフトにより、タンパク質、DNA、RNAを抽出する効率的な細胞溶解技術の必要性が高まっています。これと並行して、ゲノミクスとプロテオミクスの進歩により、高度な溶解技術の採用が加速しています。研究者が様々な種類の細胞から生体分子を分離することに注力する中、精密で拡張性のある細胞溶解手法の需要は増加の一途をたどっています。このようなアプリケーションの増加は、細胞溶解が治療開発と分子診断の両分野で重要な役割を果たすことを裏付けています。

市場促進要因

バイオ医薬品の進歩

主な市場課題

細胞溶解機器と試薬の高コスト

主要市場動向

生物製剤と個別化医療に対する需要の高まり

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の細胞溶解市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品の種類別（機器（ホモジナイザー、遠心分離機、その他の製品）、試薬）
  • 細胞の種類別（哺乳類細胞、微生物細胞、植物細胞）
  • エンドユーザー別（バイオテクノロジーまたはバイオ医薬品企業、調査機関および学術機関、その他のエンドユーザー）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の細胞溶解市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の細胞溶解市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の細胞溶解市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の細胞溶解市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの細胞溶解市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Eppendorf AG
• Hoffmann-La Roche Ltd
• Labfreez Instruments Group Co. Ltd
• Merck KGaA
• Qsonica LLC
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Cell Lysis Market was valued at USD 3.16 billion in 2024 and is projected to reach USD 4.87 billion by 2030, growing at a CAGR of 7.47% during the forecast period. This market is witnessing significant growth due to the increasing demand for cell-based research and diagnostic applications in the pharmaceutical, biotechnology, and healthcare sectors. Cell lysis-breaking open cells to access their internal components-is a foundational step in molecular biology, bioprocessing, and clinical diagnostics.

The biopharmaceutical industry's expansion and the shift toward targeted therapies and personalized medicine have intensified the need for efficient cell lysis techniques to extract proteins, DNA, and RNA. In parallel, advancements in genomics and proteomics are accelerating the adoption of advanced lysis technologies. As researchers focus on biomolecular isolation from various cell types, the demand for precise and scalable cell lysis methods continues to grow. This rising application spectrum reinforces cell lysis as a critical enabler in both therapeutic development and molecular diagnostics.

Key Market Drivers

Biopharmaceutical Advancements

The accelerating growth of the biopharmaceutical industry is a central force driving the global cell lysis market. With increasing focus on biologics and personalized medicine, pharmaceutical companies rely on advanced cell lysis methods to extract therapeutic proteins, DNA, and RNA.

Cell lysis enhances the efficiency of drug development by facilitating rapid extraction and purification of target biomolecules. This is crucial for reducing time-to-market, especially during health crises where expedited drug development is vital. Biomanufacturing processes, including antibody and protein production, depend on optimized lysis techniques to increase yield and maintain product quality.

As the complexity of therapeutic molecules increases, advanced cell lysis tools help ensure high purity and minimize contamination, which is essential for patient safety and regulatory compliance. This growing reliance on cell lysis across the drug discovery and development lifecycle ensures sustained demand for high-performance lysis products and systems.

Key Market Challenges

High Cost of Cell Lysis Equipment and Reagents

A notable challenge in the global cell lysis market is the high cost associated with equipment and reagents. High-performance instruments, such as automated and high-pressure lysis systems, require significant capital investment, which can restrict access for smaller laboratories or institutions with limited funding.

Moreover, premium-grade reagents-including enzymes, detergents, and buffers-are necessary for specific applications but can be prohibitively expensive for routine use, especially in developing countries. This limits the adoption of advanced lysis solutions and contributes to disparities in research capabilities across different regions.

Budget constraints in academic or underfunded institutions further exacerbate this issue, potentially hindering innovations in therapeutic and diagnostic research where reliable lysis techniques are essential.

Key Market Trends

Rising Demand for Biologics and Personalized Medicine

A prominent trend shaping the cell lysis market is the increasing focus on biologics and personalized therapies. The development of complex biologics-such as monoclonal antibodies, gene therapies, and vaccines-requires efficient cell lysis processes for the extraction of high-quality biomolecules.

As personalized medicine gains traction, diagnostic labs are using cell lysis to isolate DNA, RNA, and proteins for genetic profiling and biomarker analysis. This enables clinicians to tailor treatments based on individual patient data, improving efficacy and minimizing side effects.

With the biopharmaceutical industry continuously innovating in molecular and precision medicine, cell lysis systems are evolving to support specific needs in both upstream and downstream processes, ensuring compatibility with high-throughput, scalable workflows.

Key Market Players

• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Eppendorf AG
• Hoffmann-La Roche Ltd
• Labfreez Instruments Group Co. Ltd
• Merck KGaA
• Qsonica LLC
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Cell Lysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Lysis Market, By Type of Product:

• Instruments
• Reagents

Cell Lysis Market, By Type of Cells:

• Mammalian Cells
• Microbial Cells
• Plant Cells

Cell Lysis Market, By End User:

• Biotechnology or Biopharmaceutical Companies
• Research Laboratories and Academic Institutes
• Other End Users

Cell Lysis Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Lysis Market.

Available Customizations:

Global Cell Lysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Lysis Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Product (Instruments {Homogeniser, Centrifugation, Other Types of Products}, Reagents)
  • 5.2.2. By Type of cells (Mammalian Cells, Microbial Cells, Plant Cells)
  • 5.2.3. By End user (Biotechnology or Biopharmaceutical Companies, Research Laboratories and Academic Institutes, Other End Users)
  • 5.2.4. By Company (2024)
  • 5.2.5. By Region
• 5.3. Market Map

6. North America Cell Lysis Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Product
  • 6.2.2. By Type of cells
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cell Lysis Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Product
      • 6.3.1.2.2. By Type of cells
      • 6.3.1.2.3. By End user
  • 6.3.2. Mexico Cell Lysis Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Product
      • 6.3.2.2.2. By Type of cells
      • 6.3.2.2.3. By End user
  • 6.3.3. Canada Cell Lysis Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Product
      • 6.3.3.2.2. By Type of cells
      • 6.3.3.2.3. By End user

7. Europe Cell Lysis Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Product
  • 7.2.2. By Type of cells
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cell Lysis Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Product
      • 7.3.1.2.2. By Type of cells
      • 7.3.1.2.3. By End user
  • 7.3.2. Germany Cell Lysis Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Product
      • 7.3.2.2.2. By Type of cells
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Cell Lysis Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Product
      • 7.3.3.2.2. By Type of cells
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Cell Lysis Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Product
      • 7.3.4.2.2. By Type of cells
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Cell Lysis Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Product
      • 7.3.5.2.2. By Type of cells
      • 7.3.5.2.3. By End user

8. Asia-Pacific Cell Lysis Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Product
  • 8.2.2. By Type of cells
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cell Lysis Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Product
      • 8.3.1.2.2. By Type of cells
      • 8.3.1.2.3. By End user
  • 8.3.2. India Cell Lysis Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Product
      • 8.3.2.2.2. By Type of cells
      • 8.3.2.2.3. By End user
  • 8.3.3. South Korea Cell Lysis Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Product
      • 8.3.3.2.2. By Type of cells
      • 8.3.3.2.3. By End user
  • 8.3.4. Japan Cell Lysis Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Product
      • 8.3.4.2.2. By Type of cells
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Cell Lysis Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Product
      • 8.3.5.2.2. By Type of cells
      • 8.3.5.2.3. By End user

9. South America Cell Lysis Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Product
  • 9.2.2. By Type of cells
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cell Lysis Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Product
      • 9.3.1.2.2. By Type of cells
      • 9.3.1.2.3. By End user
  • 9.3.2. Argentina Cell Lysis Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Product
      • 9.3.2.2.2. By Type of cells
      • 9.3.2.2.3. By End user
  • 9.3.3. Colombia Cell Lysis Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Product
      • 9.3.3.2.2. By Type of cells
      • 9.3.3.2.3. By End user

10. Middle East and Africa Cell Lysis Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Product
  • 10.2.2. By Type of cells
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cell Lysis Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Product
      • 10.3.1.2.2. By Type of cells
      • 10.3.1.2.3. By End user
  • 10.3.2. Saudi Arabia Cell Lysis Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Product
      • 10.3.2.2.2. By Type of cells
      • 10.3.2.2.3. By End user
  • 10.3.3. UAE Cell Lysis Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Product
      • 10.3.3.2.2. By Type of cells
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Becton, Dickinson and Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Bio-Rad Laboratories Inc.
• 15.3. Danaher Corporation
• 15.4. Eppendorf AG
• 15.5. Hoffmann-La Roche Ltd
• 15.6. Labfreez Instruments Group Co. Ltd
• 15.7. Merck KGaA
• 15.8. Qsonica LLC
• 15.9. Takara Bio Inc.
• 15.10. Thermo Fisher Scientific Inc.

16. Strategic Recommendations

17. About Us & Disclaimer